Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Evaluation of the Impact of Three Different Pre-Transplant Strategies On the Outcome of Myeloma Patients Candidates to High-Dose Therapy.

Alessandro Corso, Silvia Mangiacavalli, Luciana Barbarano, Annalisa Citro, Paola Brasca, Luigi Montalbetti, Patrizia Zappasodi, Federica Cocito, Marzia Varettoni, MD, Mario Lazzarino, MD, Enrica Morra, MD

Blood (2009) 114 (22): 1223.

https://doi.org/10.1182/blood.V114.22.1223.1223

Published: 2009

Journal Articles

Coexistence of Trisomy 8 as Both Clonal and Adjunctive Cytogenetic Abnormality in Philadelphia-Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients on Treatment with Tirosine Kinase Inhibitors (TKIs): Report of Two Cases

Ester Pungolino, Silvia Cantoni, Cecilia Del Curto, Cristina Gabutti, Marianna Caramella, Luciana Barbarano, Michela Draisci, Enrica Morra

Blood (2008) 112 (11): 4884.

https://doi.org/10.1182/blood.V112.11.4884.4884

Published: 2008

Journal Articles

Bortezomib with HIG-Dose Dexamethasone as First Line Therapy in Patients with Multiple Myeloma Candidates to High-Dose Therapy.

Alessandro Corso, Luciana Barbarano, Silvia Mangiacavalli, Luigi Montalbetti, Paola Brasca, Patrizia Zappasodi, Angelo Carella, Mauro Spriano, Emilio Paolo Alessandrino, Roberto Cairoli, Daniela Petrò, Marzia Varettoni, Paolo Bernasconi, Mario Lazzarino, Enrica Morra

Blood (2007) 110 (11): 3595.

https://doi.org/10.1182/blood.V110.11.3595.3595

Published: 2007

Journal Articles

Prognostic Significance of CD33, CD34 and CD117 Expression on Bone Marrow Blasts of Patients with Myelodysplastic Syndromes.

Guido Nador, Alfredo Molteni, Clara Cesana, Michele Nichelatti, Barbara Scarpati, Roberto Cairoli, Luciana Barbarano, Annamaria Nosari, Enrica Morra

Blood (2007) 110 (11): 4604.

https://doi.org/10.1182/blood.V110.11.4604.4604

Published: 2007

Journal Articles

Low Efficacy of Thalidomide in Improving Response after Induction in Myeloma Patients Candidate to High-Dose Therapy.

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Luciana Barbarano, MD, Patrizia Zappasodi, MD, Luciano Banfi, MD, Luigi Montalbetti, MD, Antonio Mazzone, MD, Sergio Fava, MD, Guido Frigerio, MD, Luciano Isa, MD, Sergio Montanara, MD, Daniele Perego, MD, Maria Savarè, MD, Lilj Uziel, MD, Alessandro Vismara, MD, Leonardo Campiotti, MD, Mario Fiumanò, MD, Mario Lazzarino, MD, Enrica Morra, MD

Blood (2006) 108 (11): 3567.

https://doi.org/10.1182/blood.V108.11.3567.3567

Published: 2006

NARROW

Evaluation of the Impact of Three Different Pre-Transplant Strategies On the Outcome of Myeloma Patients Candidates to High-Dose Therapy.

Coexistence of Trisomy 8 as Both Clonal and Adjunctive Cytogenetic Abnormality in Philadelphia-Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients on Treatment with Tirosine Kinase Inhibitors (TKIs): Report of Two Cases

Bortezomib with HIG-Dose Dexamethasone as First Line Therapy in Patients with Multiple Myeloma Candidates to High-Dose Therapy.

Prognostic Significance of CD33, CD34 and CD117 Expression on Bone Marrow Blasts of Patients with Myelodysplastic Syndromes.

Low Efficacy of Thalidomide in Improving Response after Induction in Myeloma Patients Candidate to High-Dose Therapy.

Email alerts

ASH Publications

American Society of Hematology

Evaluation of the Impact of Three Different Pre-Transplant Strategies On the Outcome of Myeloma Patients Candidates to High-Dose Therapy.

Coexistence of Trisomy 8 as Both Clonal and Adjunctive Cytogenetic Abnormality in Philadelphia-Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients on Treatment with Tirosine Kinase Inhibitors (TKIs): Report of Two Cases

Bortezomib with HIG-Dose Dexamethasone as First Line Therapy in Patients with Multiple Myeloma Candidates to High-Dose Therapy.

Prognostic Significance of CD33, CD34 and CD117 Expression on Bone Marrow Blasts of Patients with Myelodysplastic Syndromes.

Low Efficacy of Thalidomide in Improving Response after Induction in Myeloma Patients Candidate to High-Dose Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only